Celgene Corp /de/ - Net Worth and Insider Trading
Celgene Corp /de/ Net Worth
The estimated net worth of Celgene Corp /de/ is at least $1.7 Billion dollars as of 2024-04-27. Celgene Corp /de/ is the 10% Owner of Acceleron Pharma Inc and owns about 7,008,510 shares of Acceleron Pharma Inc (XLRN) stock worth over $1.3 Billion. Celgene Corp /de/ is the 10% Owner of Agios Pharmaceuticals Inc and owns about 7,121,658 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $224 Million. Celgene Corp /de/ is also the 10% Owner of CRISPR Therapeutics AG and owns about 3,722,534 shares of CRISPR Therapeutics AG (CRSP) stock worth over $201 Million. Besides these, Celgene Corp /de/ also holds Adynxx Inc (ADYX) . Details can be seen in Celgene Corp /de/'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Celgene Corp /de/ has not made any transactions after 2020-07-09 and currently still holds the listed stock(s).
Transaction Summary of Celgene Corp /de/
Celgene Corp /de/ Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Celgene Corp /de/ owns 10 companies in total, including Acceleron Pharma Inc (XLRN) , Agios Pharmaceuticals Inc (AGIO) , and Sutro Biopharma Inc (STRO) among others .
Click here to see the complete history of Celgene Corp /de/’s form 4 insider trades.
Insider Ownership Summary of Celgene Corp /de/
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XLRN | Acceleron Pharma Inc | 2020-07-09 | 10 percent owner |
AGIO | Agios Pharmaceuticals Inc | 2019-11-12 | 10 percent owner |
STRO | Sutro Biopharma Inc | 2018-09-26 | 10 percent owner |
JUNO | Juno Therapeutics Inc | 2018-03-05 | 10 percent owner |
CRSP | CRISPR Therapeutics AG | 2017-12-04 | 10 percent owner |
ADYX | Adynxx Inc | 2017-04-11 | 10 percent owner |
JNCE | Jounce Therapeutics Inc | 2017-01-26 | 10 percent owner |
GBIM | GlobeImmune Inc | 2014-07-08 | 10 percent owner |
EPZM | Epizyme Inc | 2013-05-30 | 10 percent owner |
CASI | CASI Pharmaceuticals Inc | 2005-03-31 | 10 percent owner |
Celgene Corp /de/ Latest Holdings Summary
Celgene Corp /de/ currently owns a total of 4 stocks. Among these stocks, Celgene Corp /de/ owns 7,008,510 shares of Acceleron Pharma Inc (XLRN) as of July 9, 2020, with a value of $1.3 Billion and a weighting of 74.67%. Celgene Corp /de/ owns 7,121,658 shares of Agios Pharmaceuticals Inc (AGIO) as of November 12, 2019, with a value of $224 Million and a weighting of 13.37%. Celgene Corp /de/ also owns 3,722,534 shares of CRISPR Therapeutics AG (CRSP) as of December 4, 2017, with a value of $201 Million and a weighting of 11.96%. The other 1 stocks Adynxx Inc (ADYX) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Celgene Corp /de/
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XLRN | Acceleron Pharma Inc | 2020-07-09 | 7,008,510 | 178.75 | 1,252,771,163 |
AGIO | Agios Pharmaceuticals Inc | 2019-11-12 | 7,121,658 | 31.49 | 224,261,010 |
CRSP | CRISPR Therapeutics AG | 2017-12-04 | 3,722,534 | 53.91 | 200,681,808 |
ADYX | Adynxx Inc | 2017-02-27 | 117,435 | 0.00 | 12 |
Holding Weightings of Celgene Corp /de/
Celgene Corp /de/ Form 4 Trading Tracker
According to the SEC Form 4 filings, Celgene Corp /de/ has made a total of 2 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 2,241 shares on July 9, 2020, which brought Celgene Corp /de/ around $229,209.
According to the SEC Form 4 filings, Celgene Corp /de/ has made a total of 1 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Agios Pharmaceuticals Inc is the acquisition of 403,225 shares on November 12, 2019, which cost Celgene Corp /de/ around $13 Million.
According to the SEC Form 4 filings, Celgene Corp /de/ has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 1,112,446 shares on December 4, 2017, which brought Celgene Corp /de/ around $21 Million.
More details on Celgene Corp /de/'s insider transactions can be found in the Insider Trading History of Celgene Corp /de/ table.Insider Trading History of Celgene Corp /de/
- 1
Celgene Corp /de/ Trading Performance
GuruFocus tracks the stock performance after each of Celgene Corp /de/'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Celgene Corp /de/ is 10.74%. GuruFocus also compares Celgene Corp /de/'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Celgene Corp /de/ within 3 months outperforms 9 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Celgene Corp /de/'s insider trading performs compared to the benchmark.
Performance of Celgene Corp /de/
Average Return
-0.38%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 9.36 | 10.74 | 8.02 | -0.38 | 4.9 | -2.22 |
Relative Return to S&P 500(%) | 8.28 | 6.78 | 1.7 | -13.99 | -5.75 | -11.83 |
Celgene Corp /de/ Ownership Network
Ownership Network List of Celgene Corp /de/
Ownership Network Relation of Celgene Corp /de/
Celgene Corp /de/ Owned Company Details
What does Acceleron Pharma Inc do?
Who are the key executives at Acceleron Pharma Inc?
Celgene Corp /de/ is the 10 percent owner of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .
Acceleron Pharma Inc (XLRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acceleron Pharma Inc Insider Transactions
Celgene Corp /de/ Mailing Address
Above is the net worth, insider trading, and ownership report for Celgene Corp /de/. You might contact Celgene Corp /de/ via mailing address: 86 Morris Avenue, Summit Nj 07901.